Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement.
The ability of antiserum against murine L1210 leukemia to remove residual leukemia cells from murine bone marrow was investigated. Leukemic marrow was treated in vitro with antiserum and complement and used to hematologically reconstitute mice that had been irradiated with doses lethal to bone marrow. Following infusion of treated leukemic marrow, normal marrow returned without evidence of leukemia. More than 90 percent of the animals have survived for 11 months without untoward effects, suggesting that the technique may be of use in the treatment of acute leukemia in humans.
D000818:Animals; D000906:Antibodies; D016026:Bone Marrow Transplantation; D002470:Cell Survival; D003165:Complement System Proteins; D003602:Cytotoxicity, Immunologic; D005260:Female; D007939:Leukemia L1210 / Q000276:immunology* / Q000628:therapy; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA
D000906:Antibodies; D003165:Complement System Proteins